Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +3.20% | +9.79% | +10.73% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.73% | 35.25M | |
+25.62% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.92% | 332B | |
+3.02% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.30% | 145B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 Revenue $114,000